U.S. flag An official website of the United States government

U.S. Food and Drug Administration
  1. Home
  2. About FDA
  3. FDA Oncology Center of Excellence Presents: Conversations on Cancer: Strength in Numbers, Increasing Cancer Awareness while Decreasing Disparities - 04/23/2024
  1. About FDA

Webcast | Virtual

Event Title
FDA Oncology Center of Excellence Presents: Conversations on Cancer: Strength in Numbers, Increasing Cancer Awareness while Decreasing Disparities
April 23, 2024

Date:
April 23, 2024
Time:
2:30 PM - 4:00 PM ET
Image
Conversations on Cancer

Location:

YouTube Live Stream

Organized By:

Oncology Center of Excellence

Twitter: #ConversationsOnCancer 
Sponsored by the U.S. Food & Drug Administration (FDA)

Registration required to attend: https://www.surveymonkey.com/r/GMRWVWM

Background:

April is National Minority Health Month created to reduce health disparities and raise awareness about improving the health of racial and ethnic minority communities. In March 2023, the White House also proclaimed April as National Cancer Control Month to encourage greater cancer prevention and early detection.  In appreciation of both, FDA/OCE’s Conversation on Cancer series is featuring voices of diverse cancer advocacy groups to lead this month’s public panel discussion entitled, “Strength in Numbers, Increasing Cancer Awareness While Decreasing Disparities”.

Cancer has touched nearly every American family, and it remains the second leading cause of death in the United States after heart disease. Cancer claims the lives of over 600,000 Americans a year.  Given that more than a third of all cancer cases are preventable, reducing people’s exposure to risk factors is important.  OCE supports community-based cancer reduction and prevention and efforts to enroll a diverse clinical trial population.  Many minority-supported cancer advocacy groups are working year-round encouraging cancer screenings, educating patients and families facilitating trial participation and providing patient navigation support. This installment of Conversations on Cancer is dedicated to them.

During the 90-minute public discussion the cancer advocacy groups will specifically outline: 

  • Enhancing community-based access to cancer clinical trial participation.
  • Reducing barriers to cancer screening for people living in minority and/or rural communities. 
  • Educating people living in under-served communities about patient navigation access and peer support opportunities.  

Webcast Information: 

A free-of-charge webcast of this public panel discussion will be provided. Registration for the webcast is required at the link above.

FDA plans to post archived webcast of this Conversations on Cancer program at: https://www.fda.gov/about-fda/project-community/conversations-cancer

Contact:

For any inquiries regarding this program, please send an email to: OCE-Engagement@fda.hhs.gov

 
Back to Top